Anchor My Faith

Learn more

Cardiovascular Trends

Purpose

Section 7.2.4 — Cardiovascular Trends

Purpose

The purpose of this section is to analyze cardiovascular-related laboratory trends over time and evaluate the interaction between:

  • Traditional lipid markers
  • Advanced cardiovascular markers
  • Inflammation
  • Metabolic health
  • Blood pressure history
  • Cardiac history

The goal is not simply to identify individual abnormal values but to understand the complete cardiovascular risk profile.

The primary markers reviewed include:

  • Total cholesterol
  • LDL cholesterol
  • HDL cholesterol
  • Triglycerides
  • Non-HDL cholesterol
  • Cholesterol/HDL ratio
  • ApoB
  • LDL particle number
  • Lipoprotein(a)
  • hs-CRP
  • Glucose regulation markers

Overview

Your cardiovascular laboratory history reveals a distinctive pattern that has remained consistent over several years:

Favorable Cardiovascular Factors

  • Very high HDL cholesterol.
  • Very low triglycerides.
  • Excellent glucose control.
  • Very low inflammatory markers.
  • Strong insulin sensitivity.
  • Low Lipoprotein(a).

Areas Requiring Continued Evaluation

  • Elevated LDL cholesterol.
  • Elevated ApoB.
  • Elevated LDL particle number.
  • History of hypertension.
  • History of atrial fibrillation.
  • Ascending aortic aneurysm monitoring.

The most accurate summary is:

A favorable metabolic and inflammatory profile with persistent LDL-related cardiovascular risk factors requiring individualized evaluation.

1. Traditional Lipid Trends

Total Cholesterol

Trend
DateTotal Cholesterol
2023~249 mg/dL
June 2024220 mg/dL
November 2024243 mg/dL
December 2025256 mg/dL
June 2026284 mg/dL
Interpretation

Total cholesterol has generally increased since 2024.

However, total cholesterol alone does not fully describe cardiovascular risk because it includes:

  • LDL cholesterol
  • HDL cholesterol
  • Other cholesterol particles

The complete lipid pattern must be considered.

2. LDL Cholesterol Trend

What LDL Represents

LDL cholesterol is a measure of cholesterol carried within LDL particles.

Elevated LDL has been associated with increased cardiovascular risk, particularly when associated with elevated particle number.

LDL Trend

DateLDL Cholesterol
2023~151 mg/dL
June 2024136 mg/dL
November 2024141 mg/dL
December 2025151 mg/dL
June 2026183 mg/dL
Interpretation

LDL cholesterol has remained elevated and increased in the most recent Function Health assessment.

This is the primary cardiovascular issue requiring continued evaluation.

Important considerations:

  • LDL is only one component of cardiovascular risk.
  • LDL should be interpreted with ApoB, particle number, inflammation, metabolic health, and clinical history.

3. HDL Cholesterol Trend

What HDL Represents

HDL cholesterol is commonly associated with reverse cholesterol transport and has traditionally been considered protective.

HDL Trend

DateHDL
June 202475
November 202494
December 202589
June 202682
Interpretation

HDL has remained exceptionally high.

This is one of the most consistent favorable findings in your cardiovascular profile.

4. Triglyceride Trend

Trend

DateTriglycerides
June 202450
November 202452
December 202560
June 202685
Interpretation

Triglycerides have remained very favorable.

Low triglycerides generally correlate with:

  • Improved insulin sensitivity.
  • Lower metabolic risk.
  • Improved metabolic flexibility.

5. Cholesterol/HDL Ratio

Trend

DateRatio
December 20252.9
Interpretation

The cholesterol/HDL ratio remains favorable.

This demonstrates why your cardiovascular profile requires a complete assessment rather than focusing on LDL alone.

6. Advanced Cardiovascular Markers

ApoB

Purpose

ApoB estimates the number of potentially atherogenic particles in circulation.

It may provide additional risk information beyond LDL cholesterol.

Finding

June 2026:

  • ApoB elevated.
Interpretation

The elevated ApoB is an important finding because it suggests increased numbers of cholesterol-containing particles.

This should be discussed with Dr. Yoo.

LDL Particle Number

Purpose

LDL particle number measures the number of LDL particles rather than simply the cholesterol contained within them.

Finding

June 2026:

  • LDL particle number elevated.
Interpretation

This reinforces that LDL-related risk deserves attention beyond the standard lipid panel.

Lipoprotein(a)

Finding

Lipoprotein(a) remains low.

Interpretation

This is a favorable cardiovascular finding.

Elevated Lipoprotein(a) is an inherited cardiovascular risk factor; your results do not show this additional risk factor.

7. Inflammation and Cardiovascular Risk

One of the strongest positive trends in your cardiovascular profile is inflammation control.

Relevant markers:

  • CRP: decreased from 32 (2021) to 1–2 range.
  • ESR: decreased from 71 to 6.

Interpretation

Low inflammation is an important favorable cardiovascular factor.

Your current cardiovascular profile includes:

✅ Low inflammatory activity
✅ Excellent metabolic health
✅ Favorable triglycerides
✅ High HDL

8. Metabolic Factors Affecting Cardiovascular Health

Key Findings

  • HbA1c approximately 5.4–5.5%.
  • Low fasting insulin.
  • Low leptin.
  • Normal glucose regulation.
Interpretation

Your metabolic markers suggest excellent insulin sensitivity.

This is an important protective factor.

9. Relationship to Cardiac History

Laboratory trends must be interpreted with your medical history.

Important cardiovascular conditions:

Hypertension

History:

  • Previously treated with Amlodipine.
  • Blood pressure became low enough that medication reduction was required.

Current consideration:

  • Continued blood pressure monitoring is important.

Atrial Fibrillation

History:

  • Prior atrial fibrillation.
  • Watchman implant.
  • Eliquis discontinued after Watchman management.

Current consideration:

  • Cardiovascular risk assessment should include rhythm history.

Ascending Aortic Aneurysm

History:

  • Requires continued imaging surveillance.

Current consideration:

  • Blood pressure control remains important.

Current Cardiovascular Assessment (2026)

CategoryStatus
LDL cholesterolRequires attention
ApoBElevated
LDL particle numberElevated
HDLExcellent
TriglyceridesExcellent
Lipoprotein(a)Favorable
InflammationExcellent
Glucose controlExcellent
Insulin sensitivityExcellent
Blood pressureRequires monitoring
Cardiac historyRequires continued follow-up

Physician Discussion Points

Questions for Dr. Yoo — Cardiology

1. Given the elevated LDL, ApoB, and LDL particle number, how should cardiovascular risk be interpreted in the context of:

  • Very low inflammation?
  • Excellent triglycerides?
  • High HDL?
  • Excellent metabolic markers?

2. Would additional evaluation be helpful?

Examples:

  • Coronary artery calcium scoring (if appropriate).
  • Additional imaging.
  • Repeat advanced lipid testing.

3. What LDL/ApoB targets are appropriate given:

  • Age.
  • Cardiac history.
  • Atrial fibrillation history.
  • Aortic aneurysm monitoring.

4. Should lipid-lowering therapy be reconsidered or adjusted?

Questions for Dr. George — Primary Care

  1. Should advanced lipid testing continue annually?
  2. Should ApoB become a routine monitoring marker?
  3. How should cardiovascular trends be integrated with the quarterly laboratory schedule?

Overall Interpretation

The cardiovascular laboratory story is one of balance.

Your profile demonstrates:

Major Strengths

  • Excellent metabolic health.
  • Very low inflammation.
  • Very high HDL.
  • Very low triglycerides.
  • Low Lipoprotein(a).

Areas Requiring Continued Attention

  • Elevated LDL cholesterol.
  • Elevated ApoB.
  • Elevated LDL particle number.
  • Cardiovascular history.

The most accurate summary is:

A metabolically healthy cardiovascular profile with persistent LDL-related risk factors requiring individualized cardiology evaluation and ongoing monitoring.

Related Sections

This trend analysis connects directly with:

Return to Main Inventory